Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Suhu Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
GO44900: A Phase Ib Study Evaluating Safety Efficacy Pharmacokinetics & Pharmacodynamics of Glofitamab in Comination with Gemcitabine plus Oxaliplatin in Patients from Racial-Ethnic Minorities with Relapsed or Refractory Diffuse Cell Lympho
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
05/1/26 → 01/28/27
Project: Research
-
Ntrust-2: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy in Subjects with Immune-Mediated Diseases
Schuster, M. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI) & Liu, S. (CoPI)
05/5/25 → 02/3/27
Project: Research
-
GO43878: A Phase III, Open-label, Multicenter, Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
06/26/26 → 08/29/26
Project: Research
-
Ntrust-1: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with Autoimmune Disease
Yao, Q. P. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI), Liu, S. (CoPI) & Schuster, M. (CoPI)
05/16/25 → 08/19/26
Project: Research
-
Institutional Research Grant 2022
Frohman, M. (PI), Andrzejczyk, A. (CoI), Damaghi, M. (CoI), Guillaume, A. (CoI), Houghton, J. (CoI), Lee, C. (CoI), Liu, S. (CoI), Luberto, C. (CoI), Malik, S. (CoI), Mani, K. (CoI), Prasanna, P. (CoI), Rahme, G. (CoI), Scarbrough, K. H. (CoI), Stopeck, A. (CoI), Velazquez, F. N. (CoI), Vorkas, C. K. (CoI), Wan, L. (CoI), Bandovic, J. (CoI), Li, E. (CoI), Orfanelli, T. (CoI), Qiu, Y. (CoI), Thakur, C. (CoI) & Rageul, J. (CoI)
01/1/22 → 12/31/25
Project: Research
-
Mutant KRAS downregulates the receptor for leukemia inhibitory factor (LIF) to enhance a signature of glycolysis in pancreatic cancer and lung cancer
Liu, S., Gandler, H. I., Tosic, I., Ye, D. Q., Giaccone, Z. T. & Frank, D. A., Aug 1 2021, In: Molecular Cancer Research. 19, 8, p. 1283-1295 13 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations -
CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
Egusquiaguirre, S. P., Liu, S., Tošić, I., Jiang, K., Walker, S. R., Nicolais, M., Saw, T. Y., Xiang, M., Bartel, K., Nelson, E. A. & Frank, D. A., Jan 2020, In: Neoplasia. 22, 1, p. 47-59 13 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts
Chen, C. H., Bhasin, S., Khanna, P., Joshi, M., Joslin, P. M., Saxena, R., Amin, S., Liu, S., Sindhu, S., Walker, S. R., Catalano, P., Frank, D. A., Alper, S. L., Bhasin, M. & Bhatt, R. S., Mar 1 2019, In: Oncogenesis. 8, 3, 15.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations -
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy
Liu, S., Marneth, A. E., Alexe, G., Walker, S. R., Gandler, H. I., Ye, D. Q., Labella, K., Mathur, R., Toniolo, P. A., Tillgren, M., Gokhale, P. C., Barbie, D., Mullally, A., Stegmaier, K. & Frank, D. A., Dec 11 2018, In: Blood Advances. 2, 23, p. 3428-3442 15 p.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations -
The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells
Egusquiaguirre, S. P., Yeh, J. E., Walker, S. R., Liu, S. & Frank, D. A., May 2018, In: Neoplasia. 20, 5, p. 489-498 10 p.Research output: Contribution to journal › Article › peer-review
Open Access68 Scopus citations